BANGALORE, India, Jan. 4, 2021 /PRNewswire/ -- The 3D Bioprinting Market is Segmented by Type (Magnetic 3D Bioprinting, Laser-assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D Bioprinting), by Application (Clinical Applications, Research Applications, Drug and Medical Research, Regenerative Medicine, 3D Cell Culture), : Global Opportunity Analysis and Industry Forecast, 2020–2026. This report is published on Valuates Reports in the Bioprinting Category.
The global 3D Bioprinting market size is projected to reach USD 9956.9 Million by 2026, from USD 8316 Million in 2020, at a CAGR of 18.8% during 2021-2026.
Major factors driving the growth of the 3D Bioprinting market size are technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities.
This report provides a detailed quantitative analysis of the current 3D bioprinting market size, trends, and 3D bioprinting market forecast estimations from 2021 to 2026, which assists in identifying the prevailing 3D bioprinting market opportunities.
The 3D bioprinting market size is witnessing an upward spike with the increasing spread of Covid-19. This is attributed to the increasing demand for ventilators and the lack of availability of test kits. Various 3D bioprinting companies are manufacturing respirators and ventilators to overcome the shortage of these devices.
The progress of vaccine and drug research has been accelerated by this pandemic, as scientists are using emerging technology to allow safety testing in people. In the meantime, numerous 3D bioprinting companies are focusing on artificial tissue research and development.
TRENDS INFLUENCING THE 3D BIOPRINTING MARKET SIZE
Technological advancements in the 3D bioprinting industry are expected to drive the growth of the 3D bioprinting market size. Bioprinting has emerged as a promising technology for the manufacturing of artificial tissues and organs that can revolutionize the diagnosis and treatment of various medical conditions. Bioprinting companies around the world are actively innovating in the fields of regenerative medicine, tissue engineering, and stem cell therapy.
Furthermore, increased use of 3D bioprinting in cosmetic surgeries and stem cell research activities is expected to further increase the growth of the 3D bioprinting market size during the forecast period. The large gap between demand and availability of organ transplants signifies a huge requirement amongst the patients and the physicians, and new 3D bioprinting technologies have a strong potential to meet this demand.
3D bioprinters are becoming important in drug testing and clinical trial applications as it drastically reduces the need for animal trials. The United States Food and Drug Administration's regulatory body has begun to recognize 3D bioprinting as an integrated alternative for determining drug safety and efficacy. This, in turn, is expected to fuel the growth of the 3D bioprinting market size.
Based on type, Inkjet 3D Bioprinting is expected to hold the largest 3D bioprinting market share during the forecast period. The global inkjet based 3D bioprinting market is anticipated to reach 1423.5 million by 2025, at a CAGR of 21.3% from 2017 to 2025. At the same time, Magnetic 3D bioprinting is expected to show the fastest growth during the 3D bioprinting market during the forecast period.
Based on the region, North America is expected to hold the largest 3D Bioprinting Market share during the forecast period. The growing integration of IT into the healthcare industry is expected to increase the 3D bioprinting market size in this region. Furthermore, the rising adoption of 3D bioprinting for the production of medical products is also expected to contribute to market growth.
Asia Pacific region is expected to witness the highest growth rate during the forecast period. This rapid growth of the Asia-Pacific region is attributed to the increasing incidence of COVID-19 cases and the rising investment of the government in R&D.
-3D Bioprinting in Medical Market is Segmented by Type (Magnetic 3D Bioprinting, Laser-assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D Bioprinting), by Application (Hospital, Clinics, Research Labs) and by various regions.
-3D Bioprinting Equipment Market is Segmented by Type (Hydrogels, Biological Ink, Organ Class Material), by Application (Medical Apparatus And Instruments, Human Organs, The Scientific Research), and by various regions
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources